⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Thomas CarrollM.D., PH.D.

Internal Medicine · Rochester, NY 14642

NPI: 1902078413

Share:

33

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peersHigh long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)

Risk indicators are statistical patterns, not allegations. Learn more

2,851

Total Claims

$342K

Drug Cost

351

Beneficiaries

$974

Cost/Patient

Risk Score Breakdown 33/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Long-acting opioid rate+8
Elderly antipsychotic prescribing+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+705%

Opioid rate vs peers

18.0% vs 2.2% avg

-31%

Cost per patient vs peers

$974 vs $1,411 avg

+10%

Brand preference vs peers

11.6% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 705% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

18.0%

Opioid Rate

514

Opioid Claims

$113K

Opioid Cost

27.6%

Long-Acting Rate

Brand vs Generic

88% generic

Brand: 330 claims · $272K

Generic: 2,504 claims · $69K

Patient Profile

70

Avg Age

43%

Female

1.68

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About